CLA-2-29:OT:RR:NC:2:238
Ms. Freya Wilkes
Allergan Sales, LLC
2525 Dupont Drive
Irvine, CA 92612
RE: The tariff classification of AGN-237396 from France
Dear Ms. Wilkes:
In your letter dated July 25, 2013, you requested a tariff classification ruling.
The subject product, AGN-237396, is also known as 2-CF3-Dihydroergotamine. It is currently under development for the potential treatment of prolific migraines.
The applicable subheading for the AGN-237396 will be 2939.69.0000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Vegetable alkaloids, natural or reproduced by synthesis, and their salts, ethers, esters, and other derivatives: Alkaloids of rye ergot and their derivatives; salts thereof: Other.” The rate of duty will be free.
Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/.
This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov.
This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177).
A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at (646) 733-3033.
Sincerely,
Myles B. Harmon
Acting Director
National Commodity Specialist Division